Does Type of Tumor Histology Impact Survival among Patients with Stage IIIB/IV Non-Small Cell Lung Cancer Treated with First-Line Doublet Chemotherapy?

Chemotherapy regimens may have differential efficacy by histology in nonsmall cell lung cancer (NSCLC). We examined the impact of histology on survival of patients (N = 2,644) with stage IIIB/IV NSCLC who received first-line cisplatin/carboplatin plus gemcitabine (C/C+G) and cisplatin/carboplatin pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Clements, Karen M., Peltz, Gerson, Faries, Douglas E., Lang, Kathleen, Nyambose, Joshua, Earle, Craig C., Sugarman, Katherine P., Taylor, Douglas C. A., Thompson, David, Marciniak, Martin D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265238/
https://www.ncbi.nlm.nih.gov/pubmed/22482053
http://dx.doi.org/10.1155/2010/524629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265238/
https://www.ncbi.nlm.nih.gov/pubmed/22482053
http://dx.doi.org/10.1155/2010/524629

Ejemplares similares